iData’s global syringe and needle market MedCore covers both the needle market and the syringe market. Medcores include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

Global Cardiac Rhythm Management Industry Trends Overall, the global cardiac rhythm management, electrophysiology and cardiac ablation market was valued at $15 billion in 2018. This is expected to increase over the forecast period at a CAGR of 4.2% to reach $20.1 billion by 2025. Currently, the majority of the global market share is controlled by

In 2020, the U.S. peripheral vascular device market size was valued at $7.1 billion, with over 8.26 million peripheral vascular procedures performed each year. The market size is expected to increase and reach $10.4 billion by 2026. Throughout this medical market research, we analyzed 67 peripheral vascular companies across the United States and used our comprehensive

In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the

iData’s global intravascular ultrasound market MedCore covers both the peripheral IVUS market and the coronary IVUS market. Medcores include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

Global TAVI/TAVR, CEPD, and Pre-Shaped Guidewire markets are expected to increase to reach $8.4 billion, $492.3 million, and $70.9 million. The analysis includes in-depth procedure numbers, which will seemingly increase over the forecast period, along with the impact of COVID-19 on the procedure volume.

Globally, over 6 million cardiac surgery procedures were performed in 2020. The majority of these procedures were autotransfusion procedures followed by surgical heart valve procedures. Over the forecast period, all of the procedures included in this report are projected to experience growth, some faster than others, following COVID-19 headwinds. 

In 2020, the U.S. cardiac surgery market size was valued at $7.2 billion, with over 91,000 transcatheter heart valve replacement (TAVR) procedures performed every year. The market size is expected to increase at a growth rate of 7.7% to reach $12.1 billion in 2026. Throughout this medical market research, we analyzed 43 cardiac surgery companies

In 2020, the European cardiac surgery device market size was valued at €2.6 billion, with over 50,000 Transcatheter Aortic Valve Implantation (TAVI) procedures performed. Despite COVID19, the market size is expected to reach an insane €5.6 billion in 2026. Throughout this medical market research, we analyzed 40 cardiac surgery companies across 15 countries in Europe

In 2020, the global pacemaker market size was valued at $2.26 billion, with over 450,000 pacemaker procedures performed annually. The market size is expected to further increase over the forecast period and reach $2.6 billion in 2025. Throughout this medical market research, we analyzed global pacemaker companies across more than 70 countries and used our comprehensive methodology

In 2020, the global central venous catheter (CVC) market size was valued at approximately $763 million, with over 27 million CVC insertion procedures performed every year. The global market size is expected to reach $860 million in 2026. The overwhelming majority of the global central venous catheter market share was controlled by Teleflex, Becton Dickinson,

The global coronary stents market size is estimated to increase over the forecast period to reach more than $6.6 billion in 2027.  The majority of the global coronary stents market share was controlled by Boston Scientific, Medtronic and Abbott. Overall, this global market research includes an analysis of coronary stents companies spawning across more than 70 countries

In-depth market analysis for Introducer Sheaths, Coronary Catheters and Guidewires, including market size data, procedure volumes and more.

Stents are commonly used as complementary devices during conventional percutaneous transluminal angioplasty (PTA) balloon catheterization in peripheral vascular procedures. The placement of a stent mitigates some complications, such as negative remodeling and elastic recoil effects.

The global stent graft market size is expected to reach over $4.8 billion by 2026, while the surgical graft market size is projected to exceed $117 million. Currently, the majority of the global stent market share is controlled by Medtronic and W.L.Gore. AAA stent grafts continued to comprise the largest segment of the stent grafts

This global market research includes 0.014”-0.035” balloons, high-pressure balloons, large balloons greater than 12mm in diameter and specialty balloons. Specialty balloons include cryoplasty balloons, cutting balloons, scoring balloons and other balloons. The analysis also include DCBs used in the superficial femoral artery (SFA) and in AV access procedures.